Sino Bio: Clinical trials of the company's CGM products are in progress_Oriental Fortune

Post date May 11, 2022 — 21:55 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Carbon neutral sector rose 1.05%, Lanke high-tech rose 10.06% top

May 20, 2022 — 18:00

Don't be afraid of fluctuations! The April list of the 2nd "Jinhua Cai Cup" Private Equity Competition of West China Securities was released

May 20, 2022 — 18:00

Risen Energy: The company's Jintan 500MW 210 heterojunction thin-film cell pilot line has begun to use 120-micron silicon wafers and low-silver paste.

May 20, 2022 — 18:00

Risen Oriental: The devaluation of the renminbi has a positive effect on the company's export business and will have a certain positive impact on performance_Oriental Fortune Net

May 20, 2022 — 18:00

Risen Oriental: The company has a stable customer base in the United States_ Oriental Fortune Net

May 20, 2022 — 18:00

【Company Frontline】Meikang Biotech adds the concept of "fangcang cabin hospital"

May 20, 2022 — 17:59

“14th Five-Year Plan” 11 major transportation project packages announced

May 20, 2022 — 17:59

Intelligent automatic control: the company's products can be applied to the wind and solar power industry, which has a positive effect on the company's performance

May 20, 2022 — 17:59

Beingmate: The company is also actively sorting out and adjusting the large supermarket channels such as China Resources, Kidswant, and Wal-Mart

May 20, 2022 — 17:58

Home » News » Sino Bio: Clinical trials of the company's CGM products are in progress_Oriental Fortune